BeStock  

Opko Health OPK

US equityMarket cap rank #3217Diagnostics & Research
$1.39 −$0.07 (-4.79%)
Pre-market · Oct 8, 9:00 am ET · After hours $1.39 -0.02%
Open$1.42
Prev close$1.46
Day range$1.38 – $1.43
Volume2.22M
Market cap$1.04B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.8%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+33.1%
Worst reaction-16.2%

Stock move on the day after each report

+0.0%2023/Q3-6.1%2023/Q4-3.8%2024/Q1+11.7%2024/Q2+4.8%2024/Q3+6.7%2024/Q4-2.2%2025/Q1-7.0%2025/Q2+2.1%2025/Q3+0.0%2025/Q4-8.3%2026/Q1+33.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q227 Jul 2026After Market–+33.06%–
2026/Q128 Apr 2026After Market–-8.26%–
2025/Q426 Feb 2026After Market–+0.00%–
2025/Q329 Oct 2025After Market±15.7%+2.10%Within range
2025/Q231 Jul 2025After Market±15.6%-7.03%Within range
2025/Q130 Apr 2025After Market±21.7%-2.17%Within range
2024/Q427 Feb 2025After Market±33.6%+6.75%Within range
2024/Q37 Nov 2024After Market±21.0%+4.83%Within range
2024/Q27 Aug 2024After Market±23.2%+11.72%Within range
2024/Q17 May 2024After Market±28.1%-3.85%Within range
2023/Q427 Feb 2024After Market±34.3%-6.14%Within range
2023/Q36 Nov 2023After Market±97.0%+0.00%Within range
2023/Q23 Aug 2023After Market±27.9%+7.57%Within range
2023/Q13 May 2023After Market±37.4%+10.46%Within range
2022/Q423 Feb 2023After Market±48.6%-5.36%Within range
2022/Q38 Nov 2022After Market±28.6%-16.22%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Pharmaceutical$89.03M 54.4%
  • Diagnostics$74.55M 45.6%

Latest reported quarter: Q2, ended Jun 2026

Revenue$163.58M+4.3% YoY
Operating profit-$25.04M+58.3% YoY
Net profit-$8.42M+94.3% YoY
Diluted EPS-$0.01+94.7% YoY
Free cash flow-$46.50M+46.4% YoY
Operating cash flow-$43.50M

Revenue, last 8 quarters

$173.6MSep '24$183.6MDec '24$150.0MMar '25$156.8MJun '25$151.7MSep '25$148.5MDec '25$124.2MMar '26$163.6MJun '26

Net profit, last 8 quarters

$24.9MSep '24$14.0MDec '24$-67.6MMar '25$-148.4MJun '25$21.6MSep '25$-31.3MDec '25$-54.8MMar '26$-8.4MJun '26

Profitability & balance sheet

Gross margin40.8%
Operating margin-28.6%
Net margin-12.4%
Return on equity-5.9%
Return on assets-3.8%
Return on invested capital-2.7%
Current ratio3.35
Liabilities / assets35.3%
Cash & investments$300.76M
Total debt$385.69M
Net cash (debt)-$84.93M

Discussion

No comments yet — be the first to weigh in on OPK.

Leave a comment

Scroll to Top